Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Immune Technologies & Medicine GmbH.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Immune Technologies & Medicine GmbH
ClinicalTrials.gov Identifier:
NCT00824980
First received: January 16, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)